21-hydroxylase deficiency MRI: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Congenital adrenal hyperplasia due to 21-hydroxylase deficiency}} | {{Congenital adrenal hyperplasia due to 21-hydroxylase deficiency}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
==Overview== | ==Overview== | ||
On CT scan, congenital adrenal hyperplsia is characterized by bilateral symmetric enlargement of [[adrenal glands]]. | |||
==MRI Findings in Congenital adrenal hyperplasia due to 21-hydroxylase deficiency== | ==MRI Findings in Congenital adrenal hyperplasia due to 21-hydroxylase deficiency== | ||
On CT scan, congenital adrenal hyperplsia is characterized by bilateral symmetric enlargement of [[adrenal glands]]. | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] |
Revision as of 17:21, 17 September 2015
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency MRI On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency MRI |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
On CT scan, congenital adrenal hyperplsia is characterized by bilateral symmetric enlargement of adrenal glands.
MRI Findings in Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
On CT scan, congenital adrenal hyperplsia is characterized by bilateral symmetric enlargement of adrenal glands.